These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Use of control steady-state serum digoxin levels for predicting serum digoxin concentration after quinidine administration. Friedman HS; Chen TS Am Heart J; 1982 Jul; 104(1):72-6. PubMed ID: 6178280 [TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy and safety of oral cibenzoline and quinidine in ventricular arrhythmias: a randomized crossover study. Wasty N; Saksena S; Barr MJ Am Heart J; 1985 Dec; 110(6):1181-8. PubMed ID: 4072875 [TBL] [Abstract][Full Text] [Related]
9. Steady-state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. Drayer DE; Lowenthal DT; Restivo KM; Schwartz A; Cook CE; Reidenberg MM Clin Pharmacol Ther; 1978 Jul; 24(1):31-9. PubMed ID: 657716 [TBL] [Abstract][Full Text] [Related]
10. Crossover comparison of cibenzoline and quinidine in ambulatory patients with chronic ventricular arrhythmias. Mohiuddin SM; Woodruff MP; Esterbrooks DJ; Mooss AN; Hansen JM; Hilleman DE J Cardiovasc Pharmacol; 1989 Apr; 13(4):525-9. PubMed ID: 2470988 [TBL] [Abstract][Full Text] [Related]
11. Short- and long-term therapeutic efficacy of quinidine sulfate for the treatment of chronic ventricular arrhythmias. Panidis I; Morganroth J J Clin Pharmacol; 1982; 22(8-9):379-84. PubMed ID: 6752212 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness of dihydroquinidine and quinidine on ventricular ectopy after acute and chronic administration. Chimienti M; Regazzi MB; La Rovere MT; Salerno JA; Previtali M; Montericcio V; Rondanelli R; Montemartini C Cardiovasc Drugs Ther; 1988 Dec; 2(5):679-86. PubMed ID: 2484920 [TBL] [Abstract][Full Text] [Related]
13. Quinidine saliva concentrations: absence of correlation with serum concentrations at steady state. Narang PK; Carliner NH; Fisher ML; Crouthamel WG Clin Pharmacol Ther; 1983 Nov; 34(5):695-702. PubMed ID: 6627830 [TBL] [Abstract][Full Text] [Related]
14. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine. Shapiro W; Park J; Koch GG Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041 [TBL] [Abstract][Full Text] [Related]
15. Quinidine-induced ventricular flutter and fibrillation without digitalis therapy. Koster RW; Wellens HJ Am J Cardiol; 1976 Oct; 38(4):519-23. PubMed ID: 970334 [TBL] [Abstract][Full Text] [Related]
16. Incidence of proarrhythmic effects from quinidine in the outpatient treatment of benign or potentially lethal ventricular arrhythmias. Morganroth J; Horowitz LN Am J Cardiol; 1985 Oct; 56(10):585-7. PubMed ID: 3901720 [TBL] [Abstract][Full Text] [Related]
18. Clinical, electrocardiographic and follow-up observations in patients having ventricular fibrillation during Holter monitoring. Role of quinidine therapy. Denes P; Gabster A; Huang SK Am J Cardiol; 1981 Jul; 48(1):9-16. PubMed ID: 7246449 [TBL] [Abstract][Full Text] [Related]
19. Comparison of lorcainide and quinidine in the treatment of ventricular ectopy. Vlay SC; Mallis GI; Singh S; Cohn PF Chest; 1984 Jul; 86(1):80-3. PubMed ID: 6734299 [TBL] [Abstract][Full Text] [Related]
20. Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias. Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD Am J Cardiol; 1985 Jul; 56(1):84-8. PubMed ID: 4014046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]